Proponents of the use of medical marijuana like to start speeches and articles by quickly stating that cannabinoids are of proven value in treating many diseases.
Poppycock. This site has stated repeatedly: not true, not true, not true.
Now the evidence is in, and we were right. JAMA confirms that the evidence supporting the effectiveness of cannabinoids is tenuous at best. And risk of side effects with cannabinoids to treat anything is high.
Diets and dietary supplements are often used by people with multiple sclerosis (MS).
This updated Cochrane review reports on studies of dietary habits as an effective treatment for MS patients. Continue reading Diets for multiple sclerosis
Given that multiple sclerosis (MS) is associated with cognitive (reasoning) deterioration, researchers at the University of Toronto, in Ontario, determined the neuropsychological effects of cannabis use in these patients.
Listen up, Montel Williams. Continue reading Cognitive effects of street cannabis in MS patients
Cognitive impairment is common in multiple sclerosis (MS), but few studies have examined this relationship.
Researchers at MidAmerica Neuroscience Institute in Lenexa, Kansas, reported their findings during the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis. Continue reading Relationship between vitamin D and learning in MS
Fatigue is a common symptom of multiple sclerosis (MS) that challenges patients in their daily activities.
Researchers at the University of Illinois at Chicago compared teleconference to face-to-face, group-based fatigue self-management. The results were reported during the Joint Consortium of Multiple Sclerosis Centers and America’s Committee on Treatment and Research in Multiple Sclerosis meeting. Continue reading Teleconferencing for fatigue managment in MS patients
Researchers at the University of Toronto, in Ontario studied the relationship. Continue reading Neuropsychological effects of cannabis in patients with MS
Dr. Christine Gonzalez from Los Angeles, California, has written a thorough review of vitamin D.
Let’s focus on the actions of vitamin D thought to contribute to disease prevention. Continue reading Mechanisms underlying the actions of vitamin D
During the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), researchers at the AISM Rehabilitation Center in Genoa, Italy, compared Wii to a traditional rehabilitation program in patients with multiple sclerosis (MS). Continue reading Effects of the Wii Balance Board in patients with multiple sclerosis
Researchers from the University of Patras Medical School in Greece have reviewed the data.
Continue reading The status of marijuana in multiple sclerosis
Researchers from Mayo Clinic, in Scottsdale, Arizona reviewed the evidence. Continue reading Do cannabinoids reduce multiple sclerosis-related spasticity?
Attorney General Eric Holder says the US Justice Department will no longer raid medical marijuana clubs. His declaration is a fulfillment of a campaign promise by Barack Obama, and marks a major shift from the previous administration.
In fact, there’s scant support for medical marijuana based on medical science. Here’s what’s been published in just the past 6 months. Continue reading Marijuana: Politics trumps reality
Researchers from the Global Neuroscience Initiative Foundation, in Los Angeles, California reviewed the effectiveness of combined delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts on spasticity in multiple sclerosis (MS). Continue reading Treating spasticity in MS with THC and CBD extracts
In a word, “frustration.” People with multiple sclerosis (MS) use CAM because conventional treatments have many side effects and they are dissatisfied with the results. Continue reading What motivates people with MS to use CAM?
National MS Awareness Week runs from March 2nd to 8th.
Lets review the past year of CAM research in MS. Continue reading Multiple sclerosis week, 2009
During the annual meeting of the American Academy of Neurology this April, researchers from Stanford University, in California will report, “Women who have multiple sclerosis (MS) may reduce their risk for relapse after pregnancy if they breast-feed.”
The findings will stir debate. Continue reading Should mothers with MS breast-feed?
Researchers from the Medical University of South Carolina in Charleston have published a detailed review.
Their interest relates to the needs of vitamin D in the breastfeeding mother and her infant and child, but they also present a detailed and well-referenced review. Continue reading Update on vitamin D
In contrast to the anecdotal reports of benefit with cannabis, this study from researchers at the University of Toronto in Canada uncovers the downside of street cannabis in patients with multiple sclerosis (MS). Continue reading Negative effects of marijuana in multiple sclerosis
Researchers from Italy and the US studied changes in psychological symptoms, reasoning, abuse, tolerability, quality of life, fatigue, and ability to control movement in patients with multiple sclerosis (MS) who had never before been exposed to cannabis. Continue reading Response to cannabis by non-smokers with MS
Another result from Tuesday’s US election — 63% of voters in Michigan approved of letting people who are ill grow their own pot. Continue reading Michigan voters say OK to medical marijuana
 Up to two-thirds of patients with MS use CAM. Continue reading CAM use in multiple sclerosis